The global neuroendocrine tumor market is projected to grow at a CAGR of around 10% during the forecast period. The increased prevalence of the neuroendocrine tumor is generating the scope for the market growth. There are around 1 million cases of neuroendocrine tumors across the globe which is projected to increase in the future due to the sedentary lifestyles. Further, the rising prevalence of neuroendocrine tumors enhances the adoption rate of the drugs for the treatment of the disease, which in turn supports the market growth. However, the cost of the manufacturing of the drugs is higher as compared to other drugs which is likely to hinder the growth of the market in the near future.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/neuroendocrine-tumor-market
In addition, rising government initiatives, supports,and funding by various international organizations which is further projected to boost the market growth during the forecast period. Ongoing research activities regarding the development of novel drugs are also supporting the market growth. For instance, in 2018, the Neuroendocrine Tumor Research Foundation (NETRF), invested around $1.5 million for the production of Peptide Receptor Radionuclide Therapy (PRRT). Moreover, a novel drug produced by Progenics Pharmaceuticals Inc. is under clinical trials, PSMA Targeted PET Imaging Agent for the treatment of prostate cancer. Thus, heavy investments by the key players and cancer research organizations are propelling market growth.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/neuroendocrine-tumor-market
Market Segmentation
Global Neuroendocrine Tumor Market by Treatment Type
• Somatostatin Analogs (SSA)
• Targeted Therapy
• Chemotherapy
• Others
Global Neuroendocrine Tumor Market by Indication
• Lungs
• Pancreas
• Gastrointestinal
• Others
Global Neuroendocrine Tumor Market by End-User
• Hospital& Clinics
• Others
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• AVEO Pharmaceuticals Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Dauntless Pharmaceuticals, Inc.
• Eli Lilly & Co.
• Exelixis, Inc.
• F. Hoffmann-La Roche Ltd.
• Hutchison MediTechLtd.
• Ipsen Group
• Mateon Therapeutics, Inc.
• Novartis International AG
• Pfizer Inc.
• Progenics Pharmaceuticals, Inc.
• Tarveda Therapeutics, Inc.
• Teva Pharmaceutical Industries, Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neuroendocrine-tumor-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404